Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 70 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Cholongitas, Evangelos  [Clear All Filters]
Journal Article
Cholongitas, E., Haidich A-B., Apostolidou-Kiouti F., Chalevas P., & Papatheodoridis G. V. (2018).  Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review.. Ann Gastroenterol. 31(4), 480-490.
Pipili, C., Ilonidis G., & Cholongitas E. (2011).  Hepatitis C virus and kidney: a strong association with different clinical aspects.. Liver Int. 31(8), 1071-80.
Oikonomou, T., Goulis I., Soulaidopoulos S., Karasmani A., Doumtsis P., Tsioni K., et al. (2017).  High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis.. Ann Gastroenterol. 30(2), 217-224.
Senzolo, M., Nadal E., Cholongitas E., & Burroughs A. K. (2011).  Is hydrophobia necessary for the hepatologist prescribing nonselective beta-blockers in cirrhosis?. Hepatology. 53(6), 2149-50.
Cholongitas, E., & Pipili C. (2010).  Impact of burnout syndrome on gastroesophageal reflux disease and irritable bowel syndrome in health care workers.. J Clin Psychiatry. 71(2), 209-10.
Cholongitas, E., Papatheodoridis G. V., Goulis J., Vlachogiannakos J., Karatapanis S., Ketikoglou J., et al. (2015).  The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.. Ann Gastroenterol. 28(1), 109-117.
Cholongitas, E., & Burroughs A. K. (2010).  Is it difficult to obtain an optimal liver biopsy specimen?. Hepatology. 51(1), 355-6.
Cholongitas, E., Karatzi C., Spyrou S., Georgousaki C., & Dasenaki M. (2009).  Linezolid-induced complex partial seizures in a patient with epilepsy.. Scand J Infect Dis. 41(6-7), 540-1.
Cholongitas, E., Georgousaki C., Spyrou S., & Dasenaki M. (2010).  Linezolid-induced severe hyperbilirubinemia in a patient with decompensated cirrhosis.. J Infect. 60(2), 182-3.
Cholongitas, E., Papatheodoridis G. V., & Burroughs A. K. (2010).  Liver grafts from anti-hepatitis B core positive donors: a systematic review.. J Hepatol. 52(2), 272-9.
Cholongitas, E., Shusang V., Germani G., Tsochatzis E., Raimondo M. Luisa, Marelli L., et al. (2011).  Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.. Clin Transplant. 25(4), 614-24.
Cholongitas, E., Pipili C., & Ioannidou D. (2009).  Malassezia folliculitis presented as acneiform eruption after cetuximab administration.. J Drugs Dermatol. 8(3), 274-5.
Cholongitas, E., Tziomalos K., & Pipili C. (2015).  Management of patients with hepatitis B in special populations.. World J Gastroenterol. 21(6), 1738-48.
Senzolo, M., Schiff S., D'Aloiso C. Maria, Crivellin C., Cholongitas E., Burra P., et al. (2011).  Neuropsychological alterations in hepatitis C infection: the role of inflammation.. World J Gastroenterol. 17(29), 3369-74.
Cholongitas, E., Goulis I., Antoniadis N., Fouzas I., Imvrios G., Papanikolaou V., et al. (2014).  New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.. Transpl Int. 27(10), 1022-8.
Polyzos, S. A., Chrysavgis L., Vachliotis I. D., Chartampilas E., & Cholongitas E. (2023).  Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy.. Semin Cancer Biol. 93, 20-35.
Cholongitas, E., Tsochatzis E., Goulis J., & Burroughs A. K. (2010).  Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review.. Transpl Int. 23(9), 861-70.
Sinakos, E., Antoniadis N., Goulis I., Cholongitas E., Kiapidou S., Tsakni E., et al. (2016).  Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels.. Ann Gastroenterol. 29(2), 208-13.
Manousou, P., Samonakis D., Cholongitas E., Patch D., O'Beirne J., Dhillon A. P., et al. (2009).  Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.. Liver Transpl. 15(12), 1783-91.
Cholongitas, E., Agarwal B., Antoniadis N., & Burroughs A. K. (2012).  Patients with cirrhosis admitted to an intensive care unit.. J Hepatol. 57(1), 230-1; author reply 231-2.
Cholongitas, E., Papadakis E., Kaklamanis L., & Dasenaki M. (2009).  Peripheral facial palsy in elderly: not always a benign condition.. Geriatr Gerontol Int. 9(1), 100-1.
Davenport, A., Cholongitas E., Xirouchakis E., & Burroughs A. Kenneth (2011).  Pitfalls in assessing renal function in patients with cirrhosis--potential inequity for access to treatment of hepatorenal failure and liver transplantation.. Nephrol Dial Transplant. 26(9), 2735-42.
Smyk, D., Cholongitas E., Kriese S., Rigopoulou E. I., & Bogdanos D. P. (2011).  Primary biliary cirrhosis: family stories.. Autoimmune Dis. 2011, 189585.
Cholongitas, E., Germani G., & Burroughs A. K. (2010).  Prioritization for liver transplantation.. Nat Rev Gastroenterol Hepatol. 7(12), 659-68.
Cholongitas, E., Manousou P., Samonakis D., & Burroughs A. K. (2009).  Progression of HCV infection in patients with chronic kidney disease.. J Hepatol. 50(3), 621-2; author reply 622.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.